Alnylam Pharmaceuticals
ALNY
#448
Rank
S$67.50 B
Marketcap
S$510.98
Share price
-2.47%
Change (1 day)
55.62%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company